Infectious disease specialists and public health professionals from around the world gathered in the nation’s capital last week, just over a mile away from a White House that has canceled billions of dollars in research funding, repeatedly cast doubt on…
A PHASE II/III Ebola vaccine trial has begun in Congo as the Bundibugyo outbreak approaches 4,800 deaths. The first participants have received vaccinations in a major effort to evaluate protection against a deadly strain of Ebola for which no licensed…
SK Bioscience’s Global R&PD Center in Songdo, Incheon / Courtesy of SK Bioscience SK Bioscience will join global partners in a U.S. government-funded project to develop and produce a vaccine against the Bundibugyo virus, a strain of Ebola spreading in the…
TOKYO, Oct. 29, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.06 billion (USD 6.8 million1) in nine R&D projects for the development of drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and…
Experts advise some repetitive animal testing should be avoided to give people a vaccine quickly. Kenya has conducted two trials before Experts have backed plans to speed up the testing of vaccines against the Bundibugyo strain of Ebola by allowing…
Oct 28 (Reuters) – IAVI, a biomedical research organization, said on Wednesday it was awarded $36 million under a US government contract worth up to $99 million to advance development of its single-dose vaccine candidate against the Bundibugyo strain of the Ebola virus. The…
A new narrative review finds no licensed treatment or vaccine exists for Marburg virus disease as investigational antibodies, antivirals and vaccine candidates advance through early trials. News Source: Kristina Jarvis. (October 28, 2026). No licensed vaccine or drug exists as Marburg virus…
90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift. This article is part of a developing story. The Tumaini clinical trial aims to evaluate the safety and efficacy of vaccine candidates…
The trial will test multiple vaccine candidates. The first person has been inoculated in a clinical trial for a vaccine that could help protect against the viral strain behind the Ebola outbreak in the Democratic Republic of the Congo (DRC),…
A qualitative study in Kenya, South Africa, and Canada identified facilitators and barriers to COVID-19 vaccine safety surveillance and research participation. Post-market vaccine safety surveillance is essential for detecting rare adverse events following immunization (AEFIs) that pre-licensure clinical trials cannot…
New and re-emerging viruses such as Ebola, Marburg, Nipah, mpox and hantavirus: their virology, vaccines and the outbreaks they cause.
An article joins this feed when it matches these terms. Each one is also a search of its own.